RPI recruits leadership and highly skilled technology talent for companies globally. The company provides talent solutions focused on technology-enabled business transformation.

Angiodroid provides solutions for carbon dioxide angiography, aiming to improve vascular care and preserve kidney function in patients. The company offers various products such as CO2 injectors and disposables.

Angiodroid

ASUSTeK Computer Inc. researches and develops, designs, manufactures, sells, and repairs computers, communications, and consumer electronic products (3C) in Taiwan, China, Singapore, Europe, the United States, and internationally. The company offers phones and accessories, such as power banks, and adapters and cables; gaming products; laptops and two-in-one personal computers (PCs); desktop, tower, mini, stick, and all-in-one PCs, as well as chrome devices; motherboards, single-board computers, and chassis and cooling products; monitors and projectors; headphones and headsets, and sound cards; mesh WiFi systems, wireless routers and adapters, and wired networking products; and graphic cards, as well as business wireless routers and gaming router home products. It also provides computer bags, keyboards and mice, and mouse pads; optical drives and storage products comprising internal and external Blu-rays, and external and internal DVDs; and servers, server motherboards, workstations, and workstation motherboards. Further, it offers Internet information services; maintenance and operating services for information hardware; services information technology and communication products; and leases real estate property. Additionally, the company provides ink-jet print heads and digital image output technology, high-speed analog circuits, integrated circuits, industrial and medical computers, interface cards, and medical robots; invests in computer peripheral, Internet service, and automotive electronics businesses; and researches, develops, sells, and consults information system software; provides marketing support and repair services for medical computers and peripherals. ASUSTeK Computer Inc. was founded in 1989 and is headquartered in Taipei, Taiwan.

ASUSTeK Computer Inc.

DICE Therapeutics is developing transformative medicines for autoimmune and inflammatory diseases. It designs and develops innovative oral medicines targeting biologically validated immunology targets.

Metric
Company Name	RPI	Angiodroid	ASUSTeK Computer Inc.	DICE Therapeutics
Symbol			2.36K
MSH ID	COM:RPINT	COM:ANGIODROID	COM:ASUS	COM:DICETHERAPEUTICS
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Commercial & Professional Services	Healthcare & Health Services	Technology	Healthcare & Health Services
Industry	Recruitment & Staffing	Medical Devices	Computer Hardware	Biotechnology
Country	GB	IT	TW	US
Stage
Employee Count	11		7.59K
Website	rpint.com	angiodroid.com	asus.com	dicetherapeutics.com
LinkedIn
Founders

Metric
Market Cap	11.75B
Enterprise Value
Monthly Web Traffic		257
Web Traffic Growth		-0.27
Valuation
Raised Capital		345M

Metric
Revenue			14.88B
Revenue (LTM)
Revenue (NTM)
Gross Profit			2.17B
EBITDA			426.36M
Operating Income			344.41M
Net Income			491.39M
EPS			0.66
Diluted EPS			0.66
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.18
Operating Profit Margin			0.07
EBITDA Margin			0.03
Net Profit Margin			0.06
Return on Equity			0.14
Return on Assets			0.07
Return on Capital Employed			0.11

COM:RPINT

RPI

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			37.46
P/B Ratio			1.44
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			0.86
EV Multiple			17.92

Metric
Days Sales Outstanding			88.03
Days Payables Outstanding			55.52
Days Inventory Outstanding			131.51
Operating Cycle			210.06
Cash Conversion Cycle			150.98
Asset Turnover			1.04

Metric
Operating Cash Flow			1.52B
Free Cash Flow			1.45B
Cash Flow to Debt			3.00
Operating Cash Flow/Sales			0.11
Free Cash Flow Yield			0.22

Metric
Cash & Equivalents			2.44B
Accounts Receivable			125.61M
Inventory			3.79B
Goodwill			41.52M
Debt to Capitalization			0.07
Debt to Assets			0.05
Current Ratio			1.51
Quick Ratio			0.91

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue			0.04
SG&A to Revenue			0.02